Translational funding is used to ‘bridge the gap’ in development between early stage technology resulting from university research and its commercialisation.
The funding can help develop and support your opportunity by de-risking the project to potential commercial partners therefore making it more attractive. Some funding of this type is available from EI, but there are also many other translational funding streams available for academics looking to commercialise their research.
|BBSRC Impact Acceleration Account (BBSRC)||Supports translational and commercialisation activities as well as engagement with external organisations through proof of principle/concept studies, market research and secondments/placements.||Axel Thomson||Deadline for funding submissions is 30 March 2020|
|EPSRC Impact Acceleration Account (IAA)||Funding available to support collaborations with external organisations through activities including collaborative projects, secondments, travel and events.||EPSRC IAA||
|ESRC Impact Acceleration Account (IAA)||This funding supports a range of activities that aim to build relationships with external organisations and to enhance impact from social science research.||Knowledge Exchange Office||Closed awaiting next round of funding|
|Wellcome Trust Institutional Support Fund 3 (ISSF3)||
A cross-college fund that supports the strategic priorities of the University in biomedical sciences, including the translation and commercialisation of research.
|ISSF||Closed awaiting next round of funding|
|Industrial Strategy Challenge Fund (ISCF)||
ISCF is part of a £4.7 billion government investment in transformative research and innovation to respond to the Grand Challenges set within the UK’s Industrial Strategy: AI and Data Economy, Ageing Society, Clean Growth, Future of Mobility.
Through a series of targeted funding calls, ISCF supports collaborations between industry and academia to tackle these challenges, with an ultimate aim to increase UK productivity, economic growth and global competitiveness whilst also benefitting wider society.
|Rolling monthly deadlines|
|Innovate UK||Innovate UK, the UK’s innovation agency, is now part of UK Research & Innovation (UKRI). Innovate UK drives productivity and economic growth by supporting businesses to develop and realise the potential of new ideas, including those from the UK’s world-class research base.||Amy Tayler||Rolling monthly deadlines|
|MRC Confidence in Concept (CiC)||
Support for translation and commercialisation of biomedical projects that have a high potential to attract follow on translational funding, investment or industrial partnership.
Closed awaiting next round of funding
|MRC Proximity to Discovery (P2D)||
Supports industrial engagement, knowledge transfer and translational training activities in the area of drug discovery.
|Laura Rickards||This is an open call with no fixed submission deadline. However, all project end dates must not go beyond 28 February 2020.|
|STFC Impact Acceleration Account (IAA)||The fund aims to increase, advance and accelerate the achievement of Impact to UK plc from STFC funded research via industry/stakeholder engagement and commercialisation activities.||Craig Sheridan||Please submit your applications by 29 May 2020 for consideration.|
|Wellcome Trust Institutional Translational Partnership Award (iTPA)||
Support for early stage projects with a clear translational focus.